Index
1 Market Overview of In-Vitro Diagnostic
1.1 In-Vitro Diagnostic Market Overview
1.1.1 In-Vitro Diagnostic Product Scope
1.1.2 In-Vitro Diagnostic Market Status and Outlook
1.2 Global In-Vitro Diagnostic Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global In-Vitro Diagnostic Market Size by Region (2018-2029)
1.4 Global In-Vitro Diagnostic Historic Market Size by Region (2018-2023)
1.5 Global In-Vitro Diagnostic Market Size Forecast by Region (2024-2029)
1.6 Key Regions, In-Vitro Diagnostic Market Size (2018-2029)
1.6.1 North America In-Vitro Diagnostic Market Size (2018-2029)
1.6.2 Europe In-Vitro Diagnostic Market Size (2018-2029)
1.6.3 Asia-Pacific In-Vitro Diagnostic Market Size (2018-2029)
1.6.4 Latin America In-Vitro Diagnostic Market Size (2018-2029)
1.6.5 Middle East & Africa In-Vitro Diagnostic Market Size (2018-2029)
2 In-Vitro Diagnostic Market by Type
2.1 Introduction
2.1.1 Test Equipment
2.1.2 Test Reagents
2.2 Global In-Vitro Diagnostic Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global In-Vitro Diagnostic Historic Market Size by Type (2018-2023)
2.2.2 Global In-Vitro Diagnostic Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America In-Vitro Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.2 Europe In-Vitro Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific In-Vitro Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America In-Vitro Diagnostic Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa In-Vitro Diagnostic Revenue Breakdown by Type (2018-2029)
3 In-Vitro Diagnostic Market Overview by Application
3.1 Introduction
3.1.1 Hospitals and Clinics
3.1.2 Diagnostic Center
3.2 Global In-Vitro Diagnostic Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global In-Vitro Diagnostic Historic Market Size by Application (2018-2023)
3.2.2 Global In-Vitro Diagnostic Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America In-Vitro Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.2 Europe In-Vitro Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific In-Vitro Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America In-Vitro Diagnostic Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa In-Vitro Diagnostic Revenue Breakdown by Application (2018-2029)
4 In-Vitro Diagnostic Competition Analysis by Players
4.1 Global In-Vitro Diagnostic Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in In-Vitro Diagnostic as of 2022)
4.3 Date of Key Players Enter into In-Vitro Diagnostic Market
4.4 Global Top Players In-Vitro Diagnostic Headquarters and Area Served
4.5 Key Players In-Vitro Diagnostic Product Solution and Service
4.6 Competitive Status
4.6.1 In-Vitro Diagnostic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott
5.1.1 Abbott Profile
5.1.2 Abbott Main Business
5.1.3 Abbott In-Vitro Diagnostic Products, Services and Solutions
5.1.4 Abbott In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Recent Developments
5.2 Johnson and Johnson
5.2.1 Johnson and Johnson Profile
5.2.2 Johnson and Johnson Main Business
5.2.3 Johnson and Johnson In-Vitro Diagnostic Products, Services and Solutions
5.2.4 Johnson and Johnson In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.2.5 Johnson and Johnson Recent Developments
5.3 BD
5.3.1 BD Profile
5.3.2 BD Main Business
5.3.3 BD In-Vitro Diagnostic Products, Services and Solutions
5.3.4 BD In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.3.5 Danaher Recent Developments
5.4 Danaher
5.4.1 Danaher Profile
5.4.2 Danaher Main Business
5.4.3 Danaher In-Vitro Diagnostic Products, Services and Solutions
5.4.4 Danaher In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.4.5 Danaher Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Profile
5.5.2 Thermo Fisher Scientific Main Business
5.5.3 Thermo Fisher Scientific In-Vitro Diagnostic Products, Services and Solutions
5.5.4 Thermo Fisher Scientific In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Scientific Recent Developments
5.6 Bio-Rad
5.6.1 Bio-Rad Profile
5.6.2 Bio-Rad Main Business
5.6.3 Bio-Rad In-Vitro Diagnostic Products, Services and Solutions
5.6.4 Bio-Rad In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.6.5 Bio-Rad Recent Developments
5.7 Hologic
5.7.1 Hologic Profile
5.7.2 Hologic Main Business
5.7.3 Hologic In-Vitro Diagnostic Products, Services and Solutions
5.7.4 Hologic In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.7.5 Hologic Recent Developments
5.8 KEM-EN-TEC Diagnostics
5.8.1 KEM-EN-TEC Diagnostics Profile
5.8.2 KEM-EN-TEC Diagnostics Main Business
5.8.3 KEM-EN-TEC Diagnostics In-Vitro Diagnostic Products, Services and Solutions
5.8.4 KEM-EN-TEC Diagnostics In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.8.5 KEM-EN-TEC Diagnostics Recent Developments
5.9 Medtronic
5.9.1 Medtronic Profile
5.9.2 Medtronic Main Business
5.9.3 Medtronic In-Vitro Diagnostic Products, Services and Solutions
5.9.4 Medtronic In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.9.5 Medtronic Recent Developments
5.10 Omega Diagnostics
5.10.1 Omega Diagnostics Profile
5.10.2 Omega Diagnostics Main Business
5.10.3 Omega Diagnostics In-Vitro Diagnostic Products, Services and Solutions
5.10.4 Omega Diagnostics In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.10.5 Omega Diagnostics Recent Developments
5.11 Ortho Clinical Diagnostics
5.11.1 Ortho Clinical Diagnostics Profile
5.11.2 Ortho Clinical Diagnostics Main Business
5.11.3 Ortho Clinical Diagnostics In-Vitro Diagnostic Products, Services and Solutions
5.11.4 Ortho Clinical Diagnostics In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.11.5 Ortho Clinical Diagnostics Recent Developments
5.12 Roche
5.12.1 Roche Profile
5.12.2 Roche Main Business
5.12.3 Roche In-Vitro Diagnostic Products, Services and Solutions
5.12.4 Roche In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.12.5 Roche Recent Developments
5.13 Siemens Healthineers
5.13.1 Siemens Healthineers Profile
5.13.2 Siemens Healthineers Main Business
5.13.3 Siemens Healthineers In-Vitro Diagnostic Products, Services and Solutions
5.13.4 Siemens Healthineers In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.13.5 Siemens Healthineers Recent Developments
5.14 Sysmex
5.14.1 Sysmex Profile
5.14.2 Sysmex Main Business
5.14.3 Sysmex In-Vitro Diagnostic Products, Services and Solutions
5.14.4 Sysmex In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.14.5 Sysmex Recent Developments
5.15 Atlas Genetics
5.15.1 Atlas Genetics Profile
5.15.2 Atlas Genetics Main Business
5.15.3 Atlas Genetics In-Vitro Diagnostic Products, Services and Solutions
5.15.4 Atlas Genetics In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.15.5 Atlas Genetics Recent Developments
5.16 ELITechGroup
5.16.1 ELITechGroup Profile
5.16.2 ELITechGroup Main Business
5.16.3 ELITechGroup In-Vitro Diagnostic Products, Services and Solutions
5.16.4 ELITechGroup In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.16.5 ELITechGroup Recent Developments
5.17 Biomerieux
5.17.1 Biomerieux Profile
5.17.2 Biomerieux Main Business
5.17.3 Biomerieux In-Vitro Diagnostic Products, Services and Solutions
5.17.4 Biomerieux In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.17.5 Biomerieux Recent Developments
5.18 Werfen
5.18.1 Werfen Profile
5.18.2 Werfen Main Business
5.18.3 Werfen In-Vitro Diagnostic Products, Services and Solutions
5.18.4 Werfen In-Vitro Diagnostic Revenue (US$ Million) & (2018-2023)
5.18.5 Werfen Recent Developments
6 North America
6.1 North America In-Vitro Diagnostic Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe In-Vitro Diagnostic Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Diagnostic Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America In-Vitro Diagnostic Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Diagnostic Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 In-Vitro Diagnostic Market Dynamics
11.1 In-Vitro Diagnostic Industry Trends
11.2 In-Vitro Diagnostic Market Drivers
11.3 In-Vitro Diagnostic Market Challenges
11.4 In-Vitro Diagnostic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List